Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc Price Chart RYTM

Historical daily share price chart and data for Rhythm Pharmaceuticals Inc since 2017 adjusted for splits and dividends. The latest closing price for Rhythm Pharmaceuticals Inc as of September 25, 2020 is $22.92.
  • In 2020 the stock opened at $23.14 and closed at $22.92 for a loss of -1% YTD.
  • In 2019 the stock opened at $26.50 and closed at $22.96 for a loss of -15%.
  • In 2018 the stock opened at $28.94 and closed at $26.88 for a loss of -8%.
  • In 2017 the stock opened at $23.21 and closed at $29.06 for a gain of 20%.
View Chart On Koyfin

Rhythm Pharmaceuticals Inc Summary

Stock Symbol: RYTM

Rhythm Pharmaceuticals Inc Company Info

Rhythm Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic disorders. The company’s lead product candidate is setmelanotide, a melanocortin-4 receptor, which is in Phase III clinical trials to treat pro-opiomelanocortin (POMC) and leptin receptor deficiency obesity, and Bardet-Biedl and Alström syndrome; and is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. It is also developing RM-853, an orally available ghrelin o-acyltransferase inhibitor that is in preclinical development for Prader-Willi syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
190.28 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of RYTM Prices